Electromedical & Electrotherapeutic Apparatus · DE · CIK 1933567
Neuraxis develops neuromodulation therapies for gastrointestinal disorders, including its IB-Stim device for abdominal pain
Comparable business profile · signals at a glance
In the 90 days to Feb 12, 2026: 2 insiders bought $1.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Hannasch BrianTenPercentOwner | Buy | 40,000 | $4.92 | $197K |
| Feb 11, 2026 | Hannasch BrianTenPercentOwner | Buy | 40,000 | $4.65 | $186K |
| Dec 23, 2025 | Aharon GilDirector | Buy | 286,138 | $3.52 | $1.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.